Vice President, Regulatory Affairs
Ms. Asahi oversees HUYABIO Regulatory Affairs in Japan. With over 20 years experience in the pharmaceutical industry, she specializes in regulatory affairs and strategic biopharma regulatory affairs. Tomoko is responsible for coordination between HUYABIO and Japan’s governmental regulatory agencies, contributing to clinical and commercial strategy, New Drug Applications, post-NDA procedure handling, and Common Technical Document writing. Her pharmaceutical development experience includes oncology, CNS, vaccines, cellular therapies and biosimilars. Tomoko previously served at several Contract Research Organizations as a regulatory consultant and Eli Lilly KK. Ms. Asahi received her MPharma from the Graduate School of Biomedical and Health Sciences, Hiroshima University.